Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104What this trial is testingARID1A and/or KDM6A Mutation and CXCL13 ExpressionWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more M.D. Anderson Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 535
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Not applicableLooking for participantsNCT06414317What this trial is testingAn Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their CaregiversWho this might be right forLocally Advanced Bladder CarcinomaMetastatic Bladder CarcinomaStage III Bladder Cancer AJCC v8+2 more Roswell Park Cancer Institute 160
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Early research (Phase 1)Study completedNCT03289962What this trial is testingAutogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsWho this might be right forMelanomaNon-Small Cell Lung CancerBladder Cancer+5 more Genentech, Inc. 273
Testing effectiveness (Phase 2)Study completedNCT01023958What this trial is testingIntravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial CancerWho this might be right forNeoplasms Boehringer Ingelheim 50
Early research (Phase 1)Looking for participantsNCT07492628What this trial is testingDual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial CarcinomaWho this might be right forBladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more Beijing Biotech 42
Large-scale testing (Phase 3)Study completedNCT01627197What this trial is testingAdjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder CancerWho this might be right forBladder Cancer Sun Yat-sen University 186
Testing effectiveness (Phase 2)WithdrawnNCT06424717What this trial is testingStudy of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)Who this might be right forUrothelial Carcinoma EMD Serono Research & Development Institute, Inc.
Large-scale testing (Phase 3)UnknownNCT00949455What this trial is testingA Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the UrotheliumWho this might be right forBladder Cancer Queen Mary University of London 204
Large-scale testing (Phase 3)Study completedNCT01812369What this trial is testingPerioperative Chemotherapy for Patients With Locally Advanced Bladder CancerWho this might be right forBladder Cancer University Hospital, Rouen 500
Testing effectiveness (Phase 2)Study completedNCT02115542What this trial is testingSingle Agent Regorafenib in Refractory Advanced Biliary CancersWho this might be right forCancer of the Bile Duct H. Lee Moffitt Cancer Center and Research Institute 39
Early research (Phase 1)Ended earlyNCT03915405What this trial is testingKHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder CancerWho this might be right forUrothelial Carcinoma Kyowa Kirin, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT04892342What this trial is testingStudy of ESG401 in Adults With Solid TumorsWho this might be right forNeoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more Shanghai Escugen Biotechnology Co., Ltd 156
Testing effectiveness (Phase 2)Study completedNCT00506155What this trial is testingNeoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerWho this might be right forBladder Cancer M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT03785925What this trial is testingA Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial CancerWho this might be right forUrinary Bladder NeoplasmNeoplasm Metastasis Nektar Therapeutics 192
Large-scale testing (Phase 3)UnknownNCT02074189What this trial is testingAdjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder CancerWho this might be right forBladder Cancer Southwest Hospital, China 200